Lipocine Inc.
LPCN
$1.98
-$0.07-3.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -54.93% | 25.63% | -44.48% | -18.27% | -204.64% |
| Total Depreciation and Amortization | -1.33% | 6.38% | -12.42% | 3.21% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -131.34% | -169.43% | -37.34% | 140.63% | 155.41% |
| Change in Net Operating Assets | 359.71% | -428.76% | -38.52% | 305.43% | -82.28% |
| Cash from Operations | 22.69% | 2.22% | -58.29% | 4.22% | -215.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -730.15% | 124.08% | -84.41% | 610.15% | -214.40% |
| Cash from Investing | -730.15% | 124.08% | -84.41% | 610.15% | -215.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 351.29% | 1,777.28% | 86.90% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 351.29% | 1,777.28% | 86.90% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.58% | 160.89% | -179.68% | 194.32% | -215.77% |